Cachet Pharmaceutical Co Ltd Total Liabilities
Cachet Pharmaceutical Co Ltd total liabilities. Based on the latest financial reports, Cachet Pharmaceutical Co Ltd (002462) has total liabilities worth CN¥6.02 Billion CNY (≈ $881.58 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Cachet Pharmaceutical Co Ltd (002462) defensive interval to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Cachet Pharmaceutical Co Ltd (2007–2025)
Total liabilities of Cachet Pharmaceutical Co Ltd from 2007 to 2025. This chart illustrates how Cachet Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Cachet Pharmaceutical Co Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.
Cachet Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Cachet Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Huasu Holdings Co Ltd
SHE:000509
|
China | CN¥666.23 Million |
|
Shandong Wohua Pharmaceutical Co Ltd
SHE:002107
|
China | CN¥251.47 Million |
|
Lumibird SA
PA:LBIRD
|
France | €222.60 Million |
|
GENERAL Elevator Co. Ltd.
SHE:300931
|
China | CN¥303.63 Million |
|
Bringspring Science and Tech
SHE:300290
|
China | CN¥862.11 Million |
|
Lake Materials Co. Ltd.
KQ:281740
|
Korea | ₩254.24 Billion |
|
Smartgen (Zhengzhou) Technology Co. Ltd. A
SHE:301361
|
China | CN¥53.59 Million |
|
Caisse Regionale de Credit Agricole Mutuel de Normandie Seine SC
PA:CCN
|
France | €20.28 Billion |
Liability Composition Analysis (2007–2025)
This chart breaks down Cachet Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Cachet Pharmaceutical Co Ltd.
Liquidity & Leverage Metrics
Cachet Pharmaceutical Co Ltd Total Liabilities Ratios Explained
Cachet Pharmaceutical Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.86 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.37 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.51 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Cachet Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Cachet Pharmaceutical Co Ltd (2007–2025)
The table below shows the annual total liabilities of Cachet Pharmaceutical Co Ltd from 2007 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥6.87 Billion ≈ $1.01 Billion |
-13.80% |
| 2024-12-31 | CN¥7.97 Billion ≈ $1.17 Billion |
-27.71% |
| 2023-12-31 | CN¥11.03 Billion ≈ $1.61 Billion |
+3.71% |
| 2022-12-31 | CN¥10.64 Billion ≈ $1.56 Billion |
+14.59% |
| 2021-12-31 | CN¥9.28 Billion ≈ $1.36 Billion |
+5.35% |
| 2020-12-31 | CN¥8.81 Billion ≈ $1.29 Billion |
+8.57% |
| 2019-12-31 | CN¥8.11 Billion ≈ $1.19 Billion |
+14.01% |
| 2018-12-31 | CN¥7.12 Billion ≈ $1.04 Billion |
+18.48% |
| 2017-12-31 | CN¥6.01 Billion ≈ $879.07 Million |
+35.17% |
| 2016-12-31 | CN¥4.44 Billion ≈ $650.34 Million |
+20.61% |
| 2015-12-31 | CN¥3.68 Billion ≈ $539.21 Million |
+28.27% |
| 2014-12-31 | CN¥2.87 Billion ≈ $420.36 Million |
+93.45% |
| 2013-12-31 | CN¥1.48 Billion ≈ $217.30 Million |
+87.45% |
| 2012-12-31 | CN¥792.20 Million ≈ $115.92 Million |
+62.19% |
| 2011-12-31 | CN¥488.45 Million ≈ $71.48 Million |
+21.36% |
| 2010-12-31 | CN¥402.48 Million ≈ $58.90 Million |
+13.90% |
| 2009-12-31 | CN¥353.36 Million ≈ $51.71 Million |
+36.36% |
| 2008-12-31 | CN¥259.14 Million ≈ $37.92 Million |
-7.81% |
| 2007-12-31 | CN¥281.09 Million ≈ $41.13 Million |
-- |
About Cachet Pharmaceutical Co Ltd
Cachet Pharmaceutical Co., Ltd. engages in the wholesale, retail, and logistics of pharmaceutical products in China. The company also offers medical drugs, medical devices, e-commerce products, and warehousing logistics services. It sells its products through online and offline channels. The company was founded in 1997 and is headquartered in Beijing, China.